Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000032

Options or other derivatives

  • EVP, Chief Development Officer acquired 22,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Geary Richard S · EVP, Chief Development Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2025-01-02 Grant or award : show line 1 in the form Non-Qualified Stock Option (right to buy) +22,000 $34.69 2035-01-01 22,000 22,000 D
Loading xslF345X05/edgardoc.xml…